References
- 1. WORLD HEALTH ORGANIZATION. Global hepatitis report 2017, http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf, accessed 2nd June 2019.
- 2. DE FRANCHIS R, PRIMIGNANI M. Natural history of portal hypertension in patients with cirrhosis. Clinics in Liver Disease. 2001; 5(3):645–63.
- 3. DE FRANCHIS R. Expanding consensus in portal hypertension. Journal of Hepatology. 63(3):743–52.
- 4. BERZIGOTTI A. BT, CASTERA L., PINZANI M., DE FRANCHIS R., GENESCÀ J. Consensus Statements: Session 1–Screening and Surveillance. Portal Hypertension VI. 2016; Springer, Cham.
- 5. SPIEGEL BMR, TARGOWNIK L, DULAI GS, KARSAN HA, GRALNEK IM. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective? Hepatology (Baltimore, Md). 2003; 37(2):366–77.
- 6. SHI K-Q, FAN Y-C, PAN Z-Z, LIN X-F, LIU W-Y, CHEN Y-P, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver International. 2013; 33(1):62–71.
- 7. KIM BK, HAN K-H, PARK JY, AHN SH, KIM JK, PAIK YH, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-Viral liver cirrhosis. Am J Gastroenterol. 2010; 105(6):1382–90.
- 8. THABUT D, TRABUT J-B, MASSARD J, RUDLER M, MUNTENAU M, MESSOUS D, et al. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver International. 2006; 26(3):271–8.
- 9. AUGUSTIN S, PONS M, GENESCA J. Validating the Baveno VI recommendations for screening varices. Journal of Hepatology. 66(2):459–60.
- 10. CHEN Y, WANG W, WANG H, LI Y, SHI M, LI H, et al. Rapamycin attenuates splenomegaly in both intrahepatic and prehepatic portal hypertensive rats by blocking mTOR signaling pathway. PloS one. 2016; 11(1).
- 11. MEJIAS M, GARCIA-PRAS E, GALLEGO J, MENDEZ R, BOSCH J, FERNANDEZ M. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. Journal of Hepatology. 52(4):529–39.
- 12. TAKUMA Y, NOUSO K, MORIMOTO Y, TOMOKUNI J, SAHARA A, TAKABATAKE H, et al. Portal hypertension in patients with liver cirrhosis: diagnostic accuracy of spleen stiffness. Radiology. 2016; 279(2):609–19.
- 13. JANSEN C, BOGS C, VERLINDEN W, THIELE M, MÖLLER P, GÖRTZEN J, et al. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study. Liver International. 2017; 37(3): 396–405.
- 14. FRIEDRICH-RUST M, NIERHOFF J, LUPSOR M, SPOREA I, FIERBINTEANU-BRATICEVICI C, STROBEL D, et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. Journal of Viral Hepatitis. 2012; 19(2):e212–e9.
- 15. RIZZO L, ATTANASIO M, PINZONE MR, BERRETTA M, MALAGUARNERA M, MORRA A, et al. A new sampling method for spleen stiffness measurement based on quantitative Acoustic Radiation Force Impulse elastography for noninvasive assessment of esophageal varices in newly diagnosed HCV-related cirrhosis. BioMed Research International. 2014.
- 16. TAKUMA Y, NOUSO K, MORIMOTO Y, TOMOKUNI J, SAHARA A, TOSHIKUNI N, et al. Measurement of spleen stiffness by Acoustic Radiation Force Impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology. 144(1): 92–101.e2.
- 17. PARK Y, KIM SU, PARK SY, KIM BK, PARK JY, KIM DY, et al. A novel model to predict esophageal varices in patients with compensated cirrhosis using Acoustic Radiation Force Impulse elastography. PloS one. 2015; 10(3).
- 18. YE X-P, RAN H-T, CHENG J, ZHU Y-F, ZHANG D-Z, ZHANG P, et al. Liver and spleen stiffness measured by Acoustic Radiation Force Impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic Hepatitis B. Journal of Ultrasound in Medicine. 2012; 31(8):1245–53.
- 19. DEFRANCHIS R PJ, BURROUGHS AK, HENDERSON JM, FLEIG W, GROSZMANN RJ, BOSCH J, SAUERBRUCH T, SOEDERLUND C. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop. J Hepatol. 1992; 15:256–61.
- 20. MA X, WANG L, WU H, FENG Y, HAN X, BU H, et al. Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis. PloS one. 2016; 11(11).
- 21. ATTIA D SB, RODT T, NEGM AA, LENZEN H, LANKISCH TO, et al. Evaluation of liver and spleen stiffness with Acoustic Radiation Force Impulse quantification elastography for diagnosing clinically significant portal hypertension. Ultraschall Med 2015. 2015; 36:603.
- 22. KIM HY, JIN EH, KIM W, LEE JY, WOO H, OH S, et al. The role of spleen stiffness in determining the severity and bleeding risk of esophageal varices in cirrhotic patients. Medicine. 2015; 94(24).
- 23. BOTA S, SPOREA I, SIRLI R, FOCSA M, POPESCU A, DANILA M, et al. Can ARFI elastography predict the presence of significant esophageal varices in newly diagnosed cirrhotic patients? Annals of hepatology. 2012; 11(4):519–25.